|
CH652145A5
(de)
|
1982-01-22 |
1985-10-31 |
Sandoz Ag |
Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
|
|
US4634666A
(en)
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
CA2050918A1
(en)
|
1990-01-12 |
1991-07-13 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
WO1992020791A1
(en)
|
1990-07-10 |
1992-11-26 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
DE69133476T2
(de)
|
1990-08-29 |
2006-01-05 |
GenPharm International, Inc., Palo Alto |
Transgene Mäuse fähig zur Produktion heterologer Antikörper
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5871907A
(en)
|
1991-05-15 |
1999-02-16 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5858657A
(en)
|
1992-05-15 |
1999-01-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
AU675916B2
(en)
|
1991-06-14 |
1997-02-27 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
JPH07503132A
(ja)
|
1991-12-17 |
1995-04-06 |
ジェンファーム インターナショナル，インコーポレイティド |
異種抗体を産生することができるトランスジェニック非ヒト動物
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
ATE203767T1
(de)
|
1992-08-21 |
2001-08-15 |
Univ Bruxelles |
Immunoglobuline ohne leichte ketten
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
DE69329974T2
(de)
|
1992-12-04 |
2001-07-19 |
Medical Research Council, London |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
ATE165866T1
(de)
|
1992-12-14 |
1998-05-15 |
Innogenetics Nv |
Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
|
|
JP3926839B2
(ja)
|
1993-09-14 |
2007-06-06 |
エピミューン，インコーポレイティド |
万能ｄｒ−結合性ペプチドを用いる免疫応答の改変
|
|
US5877218A
(en)
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US7427392B1
(en)
*
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
AUPO390396A0
(en)
|
1996-11-29 |
1996-12-19 |
Csl Limited |
Novel promiscuous T helper cell epitopes
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US5888809A
(en)
|
1997-05-01 |
1999-03-30 |
Icos Corporation |
Hamster EF-1α transcriptional regulatory DNA
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
ATE490518T1
(de)
|
1999-02-05 |
2010-12-15 |
Samsung Electronics Co Ltd |
Verfahren und vorrichtung zum wiederauffinden von texturbildern
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
EP2298809A3
(en)
|
2001-07-12 |
2012-02-15 |
FOOTE, Jefferson |
Super humanized antibodies
|
|
JP4393382B2
(ja)
|
2002-08-14 |
2010-01-06 |
三菱化学株式会社 |
中枢性タウ蛋白質特異的抗体
|
|
DE50308030D1
(de)
|
2002-11-29 |
2007-10-04 |
Boehringer Ingelheim Pharma |
Neue neomycin-phosphotransferase-gene und verfahren zur selektion von hochproduzierenden rekombinanten zellen
|
|
US7847146B2
(en)
*
|
2003-03-28 |
2010-12-07 |
Baylor College Of Medicine |
Model for neurodegenerative disorders
|
|
DE10338531A1
(de)
|
2003-08-19 |
2005-04-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Reklonierung von Produktionszellen
|
|
US20050132424A1
(en)
*
|
2003-10-21 |
2005-06-16 |
Envivo Pharmaceuticals, Inc. |
Transgenic flies expressing Abeta42-Dutch
|
|
DE602005026219D1
(de)
|
2004-10-01 |
2011-03-17 |
Max Planck Gesellschaft |
Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper
|
|
PT1820022E
(pt)
|
2004-11-10 |
2009-08-05 |
Boehringer Ingelheim Pharma |
Utilização de análise por citometria de fluxo para optimizar estratégias de conservação de bancos de células cho
|
|
CA2591665C
(en)
*
|
2004-12-20 |
2015-05-05 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing west nile virus and uses thereof
|
|
DE602005026706D1
(de)
|
2004-12-30 |
2011-04-14 |
Us Government |
Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung
|
|
JP2009506790A
(ja)
*
|
2005-09-07 |
2009-02-19 |
メディミューン，エルエルシー |
毒素とコンジュゲートしたｅｐｈ受容体抗体
|
|
US8012936B2
(en)
*
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
WO2007149293A2
(en)
*
|
2006-06-16 |
2007-12-27 |
Envivo Pharmaceutical, Inc. |
Transgenic flies expressing tau and amyloid precursor fragment
|
|
WO2007147213A1
(en)
*
|
2006-06-22 |
2007-12-27 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
|
US20080124760A1
(en)
|
2006-07-26 |
2008-05-29 |
Barbara Enenkel |
Regulatory Nucleic Acid Elements
|
|
US20100216703A1
(en)
*
|
2006-08-14 |
2010-08-26 |
The Regents Of The University Of California |
Inhibitors of PDE4 and Methods of Use
|
|
CA2671457C
(en)
*
|
2006-12-01 |
2017-09-26 |
Medarex, Inc. |
Human antibodies that bind cd22 and uses thereof
|
|
EP2583978B1
(en)
|
2007-02-23 |
2016-04-06 |
Prothena Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
|
DK2126093T3
(da)
|
2007-03-02 |
2013-01-07 |
Boehringer Ingelheim Pharma |
Forbedring af proteinfremstilling
|
|
EP2031064A1
(de)
|
2007-08-29 |
2009-03-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verfahren zur Steigerung von Proteintitern
|
|
JP2009056790A
(ja)
|
2007-09-03 |
2009-03-19 |
Takao Otogawa |
ファイル用ポケット
|
|
AU2008303796B2
(en)
|
2007-09-26 |
2014-09-18 |
Amgen Inc. |
Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
|
|
EP2500362A3
(en)
*
|
2007-11-13 |
2012-10-24 |
Teva Biopharmaceuticals USA, Inc. |
Humanized antibodies against TL1A
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
JP2010014691A
(ja)
*
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び／又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
|
PE20110774A1
(es)
*
|
2008-08-18 |
2011-10-13 |
Amgen Fremont Inc |
Anticuerpos para ccr2
|
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
|
CN104231084B
(zh)
|
2009-05-13 |
2019-04-23 |
基酶有限公司 |
抗人cd52免疫球蛋白
|
|
CA3120504A1
(en)
*
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
|
US20110045534A1
(en)
*
|
2009-08-20 |
2011-02-24 |
Cell Signaling Technology, Inc. |
Nucleic Acid Cassette For Producing Recombinant Antibodies
|
|
WO2011026031A1
(en)
|
2009-08-28 |
2011-03-03 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind tau oligomers
|
|
WO2011053565A2
(en)
|
2009-10-29 |
2011-05-05 |
Biomedical Sciences Research Centre "Alexander Fleming" |
Compositions and methods for detecting a tauopathy
|
|
WO2011075636A2
(en)
*
|
2009-12-18 |
2011-06-23 |
Amgen Inc. |
Wise binding agents and epitopes
|
|
JP5697044B2
(ja)
|
2010-01-08 |
2015-04-08 |
国立大学法人京都大学 |
タウオパチー治療用ワクチン
|
|
BR112012020373A8
(pt)
|
2010-02-23 |
2018-01-02 |
Genentech Inc |
anticorpo isolado, célula, ácido nucleico isolado, método de identificação, de inibição da proliferação de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína tat419, de diagnóstico da presença de câncer e de distribuição de agente citotóxico
|
|
WO2011130377A2
(en)
|
2010-04-15 |
2011-10-20 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
|
EP2560681A4
(en)
|
2010-04-22 |
2013-09-25 |
Janssen Alzheimer Immunotherap |
USE OF TAU FOR MONITORING IMMUNOTHERAPY
|
|
ITRM20100320A1
(it)
*
|
2010-06-11 |
2011-12-11 |
Consiglio Nazionale Ricerche |
Metodo per la diagnostica e il trattamento delle taupatie
|
|
US20120023911A1
(en)
|
2010-07-28 |
2012-02-02 |
Gm Global Technology Operations, Inc. |
Detection of exhaust particulate filter substrate failure
|
|
MX345092B
(es)
*
|
2010-10-11 |
2017-01-17 |
Univ Zuerich |
Anticuerpos anti-tau humanos,.
|
|
AR084210A1
(es)
*
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
JP2014511174A
(ja)
*
|
2011-02-07 |
2014-05-15 |
ネオトープ バイオサイエンシーズ リミテッド |
Ａｐｏｅ免疫療法
|
|
US8697076B2
(en)
|
2011-04-27 |
2014-04-15 |
Northwestern University |
Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
|
|
GB201109238D0
(en)
|
2011-06-01 |
2011-07-13 |
Antitope Ltd |
Antibodies
|
|
GB201111361D0
(en)
*
|
2011-07-04 |
2011-08-17 |
Nordic Bioscience As |
Biochemical markers for neurodegenerative conditions
|
|
GB201112056D0
(en)
*
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
CA2845884A1
(en)
*
|
2011-08-22 |
2013-02-28 |
Cangene Corporation |
Clostridium difficile antibodies
|
|
CN109265543B
(zh)
|
2011-09-19 |
2022-04-26 |
阿克松神经系统科学公司 |
阿尔茨海默病中的tau蛋白介导病变的基于蛋白质的疗法和诊断
|
|
TW201817745A
(zh)
|
2011-09-30 |
2018-05-16 |
日商中外製藥股份有限公司 |
具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
|
|
ES2600915T3
(es)
|
2011-10-07 |
2017-02-13 |
Ac Immune S.A. |
Anticuerpos fosfoespecíficos que reconocen Tau
|
|
KR102035882B1
(ko)
|
2012-03-28 |
2019-10-24 |
사노피 |
브라디키닌 b1 수용체 리간드에 대한 항체
|
|
WO2013151762A1
(en)
|
2012-04-05 |
2013-10-10 |
Ac Immune S.A. |
Humanized tau antibody
|
|
EP2839077B1
(en)
|
2012-04-18 |
2016-03-02 |
E. I. du Pont de Nemours and Company |
Multilayered sheet
|
|
DE102012211455A1
(de)
|
2012-07-02 |
2014-01-02 |
Wobben Properties Gmbh |
Handhabungsvorrichtung zum Handhaben einer Rotorblattform zum Fertigen eines Rotorblattes einer Windenergieanlage
|
|
KR20150036346A
(ko)
|
2012-07-03 |
2015-04-07 |
워싱턴 유니버시티 |
Tau에 대한 항체
|
|
EA035976B1
(ru)
|
2012-08-16 |
2020-09-08 |
АйПИЕРИАН, ИНК. |
Анти-tau антитела для лечения таупатий
|
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
WO2014059442A2
(en)
|
2012-10-12 |
2014-04-17 |
Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
|
US9200068B2
(en)
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
|
ES2816700T3
(es)
|
2012-12-21 |
2021-04-05 |
Biogen Ma Inc |
Anticuerpos anti-tau humanos
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
US9364191B2
(en)
|
2013-02-11 |
2016-06-14 |
University Of Rochester |
Method and apparatus of spectral differential phase-contrast cone-beam CT and hybrid cone-beam CT
|
|
SG10201707855YA
(en)
|
2013-03-13 |
2017-10-30 |
Prothena Biosciences Ltd |
Tau immunotherapy
|
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
CA2939692C
(en)
|
2013-03-15 |
2022-10-18 |
The Trustees Of The University Of Pennsylvania |
Blood biomarkers that predict persistent cognitive dysfunction after concussion
|
|
HK1225742A1
(zh)
|
2013-08-22 |
2017-09-15 |
Acceleron Pharma, Inc. |
TGF-β受体II型变体及其用途
|
|
MX384909B
(es)
|
2013-11-27 |
2025-03-14 |
Ipierian Inc |
Un anticuerpo anti-tau para usarse al tratar una tauopatía.
|
|
EP3080611B1
(en)
|
2013-12-13 |
2018-11-14 |
The General Hospital Corporation |
Soluble high molecular weight (hmw) tau species and applications thereof
|
|
SG10201809385RA
(en)
*
|
2013-12-17 |
2018-11-29 |
Genentech Inc |
Anti-cd3 antibodies and methods of use
|
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US20150253341A1
(en)
|
2014-02-10 |
2015-09-10 |
Merck Sharp & Dohme Corp. |
Quantification of tau in biological samples by immunoaffinity enrichment and mass spectrometry
|
|
KR20170023124A
(ko)
|
2014-06-26 |
2017-03-02 |
얀센 백신스 앤드 프리벤션 비.브이. |
미세소관-연관 단백질 타우에 특이적으로 결합하는 항체 및 항원-결합 단편
|
|
TW202136296A
(zh)
|
2014-06-27 |
2021-10-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗-tau抗體
|
|
SI3221349T1
(sl)
|
2014-11-19 |
2021-02-26 |
Axon Neuroscience Se |
Humanizirano tau protitelo pri alzheimerjevi bolezni
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016137950A1
(en)
|
2015-02-24 |
2016-09-01 |
Rpeptide, Llc |
Anti-tau antibodies
|
|
EP3303386B1
(en)
|
2015-06-05 |
2024-08-28 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
|
WO2016201434A2
(en)
|
2015-06-12 |
2016-12-15 |
C2N Diagnostics, Llc |
Stable formulations of humanized anti-tau antibody
|
|
TN2017000543A1
(en)
|
2015-07-06 |
2019-04-12 |
Ucb Biopharma Sprl |
Tau-binding antibodies
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
US11327080B2
(en)
|
2015-07-21 |
2022-05-10 |
BioArctic Neruoscience AB |
Method for treatment of traumatic brain injury targeting aggregated peptides
|
|
CA2997960A1
(en)
|
2015-10-06 |
2017-04-13 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
PL3452507T3
(pl)
|
2016-05-02 |
2023-01-09 |
Prothena Biosciences Limited |
Immunoterapia tau
|
|
PE20190208A1
(es)
|
2016-05-02 |
2019-02-07 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
|
JP7481726B2
(ja)
|
2016-05-02 |
2024-05-13 |
プロセナ バイオサイエンシーズ リミテッド |
タウ認識抗体
|
|
WO2018085653A1
(en)
|
2016-11-04 |
2018-05-11 |
The Regents Of The University Of California |
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
|
|
TW202328181A
(zh)
|
2016-12-07 |
2023-07-16 |
美商建南德克公司 |
抗-tau抗體及使用方法
|
|
JP2020511937A
(ja)
|
2016-12-07 |
2020-04-23 |
ジェネンテック， インコーポレイテッド |
抗ｔａｕ抗体及び使用方法
|
|
SG11201907422RA
(en)
|
2017-02-17 |
2019-09-27 |
Denali Therapeutics Inc |
Anti-tau antibodies and methods of use thereof
|
|
CN110545844A
(zh)
|
2017-02-21 |
2019-12-06 |
瑞美德生物医药科技有限公司 |
使用结合细胞毒性t淋巴细胞抗原-4(ctla-4)的抗体的癌症治疗
|
|
JOP20180021A1
(ar)
|
2017-03-16 |
2019-01-30 |
Janssen Biotech Inc |
الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها
|
|
WO2018178077A1
(en)
|
2017-03-28 |
2018-10-04 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
|
KR20190133162A
(ko)
|
2017-03-28 |
2019-12-02 |
제넨테크, 인크. |
신경퇴행성 질병의 치료 방법
|
|
PE20200695A1
(es)
|
2017-05-02 |
2020-06-16 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
|
WO2018231254A1
(en)
|
2017-06-16 |
2018-12-20 |
Bristol-Myers Squibb Company |
Compositions and methods for treating tauopathies
|
|
UA129617C2
(uk)
|
2017-10-16 |
2025-06-18 |
Еісаі Р Енд Д Менеджмент Ко., Лтд. |
Антитіло до тау та його застосування
|
|
EP3706795A4
(en)
|
2017-11-09 |
2021-10-13 |
Pinteon Therapeutics Inc. |
METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES
|
|
CA3084098A1
(en)
|
2017-12-04 |
2019-06-13 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
|
CN112004827A
(zh)
|
2018-03-23 |
2020-11-27 |
艾伯维德国有限责任两合公司 |
稳定的水性抗tau抗体调配物
|
|
AU2019244481A1
(en)
|
2018-03-28 |
2020-10-01 |
Axon Neuroscience Se |
Antibody-based methods of detecting and treating Alzheimer's disease
|
|
EP3784274A1
(en)
|
2018-04-27 |
2021-03-03 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
AU2019377595A1
(en)
|
2018-11-08 |
2021-05-27 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
CA3118818A1
(en)
|
2018-11-08 |
2020-05-14 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
EP3883602A4
(en)
|
2018-11-19 |
2023-04-12 |
The Board Of Regents Of The University Of Texas System |
TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING TO THEM FOR THE TREATMENT OF TAUOPATHIES
|
|
EP3921343A4
(en)
|
2019-02-08 |
2022-12-14 |
Prothena Biosciences Limited |
ANTIBODIES FOR DETECTING TAU
|
|
CN113544149B
(zh)
|
2019-03-03 |
2024-11-15 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
|
JP2022526334A
(ja)
|
2019-03-25 |
2022-05-24 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
新たなタウ種を標的化することによるタウオパチー障害の処置の方法
|
|
EP4001305A4
(en)
|
2019-07-15 |
2022-10-12 |
Adel Inc. |
ANTI-TAU ANTIBODIES AND ITS USE
|